Leerink Swann Starts ZymoGenetics (ZGEN) at Outperform, $8 Price Target
Tweet Send to a Friend
Leerink Swann initiates coverage on ZymoGenetics (Nasdaq: ZGEN) with an Outperform rating and an $8 price target.
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
